NCT05055687View on ClinicalTrials.gov

Evaluation of the Safety, Tolerability and Pharmacokinetics of Intravenous FL058 Administered in Healthy Subjects(SAD/MAD)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 5, 2020

Primary Completion Date

July 27, 2020

Study Completion Date

July 27, 2020

Conditions

Healthy

Interventions

DRUG

FL058

2500mg、3000mg

DRUG

Placebo

empty bottle

DRUG

FL058

500mg、1000mg、2000mg

DRUG

Placebo

empty bottle

Trial Locations (1)

Unknown

Huashan Hospital affiliated to Fudan University, Shanghai

All Listed Sponsors

lead

Qilu Pharmaceutical Co., Ltd.

INDUSTRY

NCT05055687 - Evaluation of the Safety, Tolerability and Pharmacokinetics of Intravenous FL058 Administered in Healthy Subjects(SAD/MAD) | Biotech Hunter | Biotech Hunter